Rami A. El Shafie
Papers
2
Total Citations
18
H-Index
2
About
Rami A. El Shafie is a leading radiation oncologist whose research focuses on advancing stereotactic radiosurgery (SRS) for brain metastases, particularly through the integration of novel imaging and treatment planning technologies. His major contributions include the CYBER-SPACE trial, a single-center prospective randomized study that compared SRS outcomes for brain metastases diagnosed with SPACE versus MPRAGE MRI sequences, demonstrating how advanced imaging can refine target delineation and improve patient outcomes. This work, cited 11 times, underscores his commitment to optimizing non-invasive, less toxic alternatives to whole-brain radiotherapy, even for patients with multiple metastases. Additionally, his 2017 study on treatment planning for MLC-based robotic radiosurgery (CyberKnife M6) provided critical strategies for transitioning from circular fields to multileaf collimators, achieving superior dose conformity and normal tissue sparing for targets ranging from 1.5 to 9 cm³. With 7 citations, this work has guided clinical planning for complex cases. Dr. El Shafie’s research bridges imaging innovation and technical precision, directly enhancing the safety and efficacy of radiosurgery. His achievements position him as a key contributor to personalized, high-precision radiotherapy, offering students and researchers a model for translating technological advances into tangible clinical benefits.
Research Focus
Key Achievements
Top Papers
- 1
- 2